Pros and Cons of Nymox Pharmaceutical Corp. in the next few years
Pros
?
W********* I********* f** t** n*** y****
?
M***** P*******
?
S********** s********
Cons
?
G***** c******* t* c**********
?
B****
?
C******** o* t** e**********
Tell us your opinion to access the 'Wisdom of the Crowds'
Performance of Nymox Pharmaceutical Corp. vs. its peers
Security | Change(%) | 1w | 1m | 1y | YTD | 3y | 5y |
---|---|---|---|---|---|---|---|
Nymox Pharmaceutical Corp. | - | - | - | - | - | - | - |
Promis Neurosciences Inc. | -10.560% | 1.408% | -13.253% | -66.667% | 44.724% | -82.857% | -86.441% |
InMed Pharmaceuticals Inc. | 2.060% | 0.000% | 14.046% | -76.949% | -20.930% | -99.558% | -99.881% |
Resverlogix Corp | - | 0.000% | 0.000% | -51.333% | -15.116% | -93.917% | -98.355% |
Comments
Nymox Pharmaceutical Co. (NASDAQ: NYMX) is now covered by analysts at StockNews.com. They set a "sell" rating on the stock.
Show more
Ratings data for NYMX provided by MarketBeat
Nymox Pharmaceutical Co. (NASDAQ: NYMX) is now covered by analysts at StockNews.com. They set a "sell" rating on the stock.
Show more
Ratings data for NYMX provided by MarketBeat
Nymox Pharmaceutical Co. (NASDAQ: NYMX) is now covered by analysts at StockNews.com. They set a "sell" rating on the stock.
Show more
Ratings data for NYMX provided by MarketBeat